Researchers have been excited about this new drug, a innovative dual treatment showing significant results in initial trials for weight loss . It acts by targeting several pathways : GLP-1 and GIP, https://hannaadiw358931.targetblogs.com/41087565/a-new-prospect-for-weight-management